Building for decades: Dubai’s long game in life sciences
Editor's note: This feature was reported in part prior to the escalation of hostilities in the Gulf, when Iran launched…
All articles by Catherine Longworth
Catherine Longworth
@MedtechCate
Catherine Longworth is Healthcare Editor-in-Chief at GlobalData, where she leads coverage of updates across pharma, biotech, medical technology, and health tech. With a background in biomedical science and journalism, she has reported on healthcare developments across multiple regions since 2016, bringing a global perspective to her work. Catherine has extensive experience leading B2B publications and is recognised for delivering insightful, accurate, and forward-looking reporting. She frequently moderates international industry panels and conferences, connecting audiences with thought leaders from around the world.
-
-
Women first: the Gulf’s new healthcare blueprint
Nabta Health, a Dubai-based women's health company, is up for a prestigious MedTech award, but its founder Sophie Smith has…
-
From humble to global: China’s biotechs navigate the demands of international trials
Driven by regulatory reforms that are accelerating drug approvals and a wave of licensing deals with Western partners, Chinese life…
-
Navigating regulatory change in APAC: Insights from the upcoming BioSecure Act Webinar
The regulatory landscape across the Asia-Pacific (APAC) region is evolving rapidly, and pharmaceutical companies must adapt to maintain compliance, mitigate…
-
China’s clinical trial ecosystem takes centre stage in Suzhou this September
China’s rapid emergence as a global clinical trials powerhouse will be in sharp focus this September as leading voices from…
-
Cannabis on the NHS? Research is the gateway to wider access
“Families are fundraising to keep their children alive.” That was the stark message delivered at Cannabis Europa in London, where…
-
AI should unlock clinical trial data, say experts
Artificial intelligence (AI) has the potential to uncover valuable insights hidden in protocols and clinical study reports across the pharmaceutical…
-
Diversity commitment persists in clinical trials amidst policy shifts
Despite major policy rollbacks on diversity, equity, and inclusion (DEI) at the US federal level, clinical research leaders have made…
-
Examining shifts in clinical trial outsourcing
As clinical trials grow increasingly complex and globalised, industry leaders continue to reassess how outsourcing models can drive efficiency and…
-
Harnessing LLMs in clinical trial management
The use of large language models (LLMs) such as ChatGPT will be key in enhancing clinical trial management according to…